Parkinson's Disease (PD)
117
46
51
34
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
17 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
1.7%
2 terminated out of 117 trials
94.4%
+7.9% vs benchmark
9%
11 trials in Phase 3/4
50%
17 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (117)
Music Therapy in Parkinson's Disease
Adapted Physical Activity and Tango-Based Therapy for Parkinson's Disease: A Pilot Study
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Effectiveness of Resistance Exercises Added to Aerobic and Balance Exercises in Parkinson's Disease
Efficacy of LSVT-LOUD Therapy on Voice, Speech, and Quality of Life in Parkinson's Disease
Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease
TMS in Anxiety-Parkinson's Disease
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
A Study of Buntanetap in Participants With PD
A Study of Dimdazenil in Patients With Parkinson's Disease and Insomnia
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease
Directional PSA Versus STN DBS for TD-PD
Moving Yourself in Space and Time: MYSTIC
Coordinated Reset Deep Brain Stimulation for Parkinson's Disease
LRRK2 (Leucine-Rich Repeat Kinase 2) Parkinson's Disease Fingerprint
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
The Effects of Tele-Rehabilitation-Based Dual-Task Upper Extremity Training in Patients With Parkinson's Disease
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations
A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease